<https://www.medicalpress.es/mas-de-un-tercio-de-pacientes-con-leucemia-de-alto-riesgo-responden-a-un-nuevo-farmaco-experimental/#article>
<http://schema.org/isPartOf>
<https://www.medicalpress.es/mas-de-un-tercio-de-pacientes-con-leucemia-de-alto-riesgo-responden-a-un-nuevo-farmaco-experimental/>
<https://www.medicalpress.es/mas-de-un-tercio-de-pacientes-con-leucemia-de-alto-riesgo-responden-a-un-nuevo-farmaco-experimental/>